• Search
  • Helpdesk
  • Sales contact
Get your demo
☰

Put an end to eCOA misconceptions #infography

Last updated: June 24, 2024

Discover below the 5 reasons to adopt eCOA solutions.
Want to learn more about eCOA misconceptions? Click here!

5 reasons to adopt eCOA solutions

To download “Put an end to eCOA misconceptions”:

[tag url=”https://kayentis.com/wp-content/uploads/2020/05/put-an-end-to-ecoa-misconceptions.pdf”]

Learn more:

Follow us on social media
Subscribe to our newsletter
You may also like

Expanding investor confidence: The strategic value of Patient Reported Outcomes...

Leveraging the potential of Patient Reported Outcome (PRO) data to...

Gastrointestinal Tract Diseases Research: Moving Towards Patient-Centered Clinical Trials

The critical importance of Patient Reported Outcomes (PROs) for Emerging...

Turning experience into evidence: PROs in IBD clinical research

BYOD on the rise

About the author
Picture of Marc Chaperon

Marc Chaperon

Estelle brings 20+ years of experience in pre-clinical and clinical research from Top 5 Pharma and Biotech firms. Leading projects across Phases 1 to 4 in diverse therapeutic areas, she offers deep insights into clinical science, operations, and regulatory intricacies. Appointed as Chief Medical Officer at Kayentis in May 2019.
Meet us at the following events

DPHARM 2025

SEPT 16-17 2025 • Philadelphia, PA, USA
Booth #44 16th Annual Outsourcing in Clinical Trials East Coast 2025 - Arena International

SCDM 2025

Baltimore, Maryland, USA - 27-30 SEPT 2025
Annual Conference 2025 – SCDMLive    

SCOPE Europe 2025

OCT 14-15 2025 • Barcelona, Spain
SCOPE Europe | Summit for Clinical Operations Executives | October 14-15, 2025 |Barcelona, Spain

Kayentis Europe
19 bis, chemin du vieux Chêne
38240 Meylan
France
Phone: +33 (0)4 76 00 54 20

Kayentis US
186 South Street
Suite 600
Boston, Massachusetts 02111
USA